Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Therapeutic drug monitoring in children with HIV/AIDS.
Fraaij PL, Rakhmanina N, Burger DM, de Groot R. Fraaij PL, et al. Ther Drug Monit. 2004 Apr;26(2):122-6. doi: 10.1097/00007691-200404000-00006. Ther Drug Monit. 2004. PMID: 15228151 Review.
Efficacy of highly active antiretroviral therapy in HIV-1 infected children.
van Rossum AM, Fraaij PL, de Groot R. van Rossum AM, et al. Among authors: fraaij pl. Lancet Infect Dis. 2002 Feb;2(2):93-102. doi: 10.1016/s1473-3099(02)00183-4. Lancet Infect Dis. 2002. PMID: 11901656 Review.
Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavir.
van Rossum AM, Dieleman JP, Fraaij PL, Cransberg K, Hartwig NG, Burger DM, Gyssens IC, de Groot R. van Rossum AM, et al. Among authors: fraaij pl. Pediatrics. 2002 Aug;110(2 Pt 1):e19. doi: 10.1542/peds.110.2.e19. Pediatrics. 2002. PMID: 12165618
Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected children.
van Rossum AM, Bergshoeff AS, Fraaij PL, Hugen PW, Hartwig NG, Geelen SP, Wolfs TF, Weemaes CM, De Groot R, Burger DM. van Rossum AM, et al. Among authors: fraaij pl. Pediatr Infect Dis J. 2002 Aug;21(8):743-7. doi: 10.1097/00006454-200208000-00009. Pediatr Infect Dis J. 2002. PMID: 12192162 Clinical Trial.
Changes in indinavir exposure over time: a case study in six HIV-1-infected children.
Fraaij PL, Bergshoeff AS, van Rossum AM, Hartwig NG, Burger DM, de Groot R. Fraaij PL, et al. J Antimicrob Chemother. 2003 Oct;52(4):727-30. doi: 10.1093/jac/dkg391. Epub 2003 Aug 13. J Antimicrob Chemother. 2003. PMID: 12917234
Pharmacokinetics of nelfinavir in children: influencing factors and dose implications.
Bergshoeff AS, Fraaij PL, van Rossum AM, Wolfs TF, Geelen SP, de Groot R, Burger DM. Bergshoeff AS, et al. Among authors: fraaij pl. Antivir Ther. 2003 Jun;8(3):215-22. Antivir Ther. 2003. PMID: 12924538
A new method for analysis of AZT-triphosphate and nucleotide-triphosphates.
van Kampen JJ, Fraaij PL, Hira V, van Rossum AM, Hartwig NG, de Groot R, Luider TM. van Kampen JJ, et al. Among authors: fraaij pl. Biochem Biophys Res Commun. 2004 Feb 27;315(1):151-9. doi: 10.1016/j.bbrc.2004.01.032. Biochem Biophys Res Commun. 2004. PMID: 15013439
Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected children.
Bergshoeff AS, Fraaij PL, van Rossum AM, Verweel G, Wynne LH, Winchell GA, Leavitt RY, Nguyen BY, de Groot R, Burger DM. Bergshoeff AS, et al. Among authors: fraaij pl. Antimicrob Agents Chemother. 2004 May;48(5):1904-7. doi: 10.1128/aac.48.5.1904-1907.2004. Antimicrob Agents Chemother. 2004. PMID: 15105157 Free PMC article.
Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected children.
Fraaij PL, Neubert J, Bergshoeff AS, van Rossum AM, Hartwig NG, Schroten H, Korn K, Burger DM, de Groot R, Niehues T. Fraaij PL, et al. Antivir Ther. 2004 Apr;9(2):297-9. Antivir Ther. 2004. PMID: 15134193 Clinical Trial.
Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected children.
Bergshoeff AS, Fraaij PL, Verweij C, van Rossum AM, Verweel G, Hartwig NG, de Groot R, Burger DM. Bergshoeff AS, et al. Among authors: fraaij pl. J Antimicrob Chemother. 2004 Dec;54(6):1152-4. doi: 10.1093/jac/dkh490. Epub 2004 Nov 10. J Antimicrob Chemother. 2004. PMID: 15537694 Clinical Trial.
72 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback